These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28544)

  • 1. Tardive dyskinesia and psychotropic drug history.
    Simpson GM; Varga E; Lee JH; Zoubok B
    Psychopharmacology (Berl); 1978 Jul; 58(2):117-24. PubMed ID: 28544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia: developmental factors.
    Yassa R; Ghadirian AM; Schwartz G
    Can J Psychiatry; 1985 Aug; 30(5):344-7. PubMed ID: 2862984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychologists and psychoactive drugs.
    Murray JB
    Genet Psychol Monogr; 1978 Nov; 98(Second Half):281-323. PubMed ID: 31317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia in psychiatric patients with substance use disorders.
    Olivera AA; Kiefer MW; Manley NK
    Am J Drug Alcohol Abuse; 1990; 16(1-2):57-66. PubMed ID: 1970451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of tardive dyskinesia in psychiatric inpatients in Japan.
    Koshino Y; Madokoro S; Ito T; Horie T; Mukai M; Isaki K
    Clin Neuropharmacol; 1992 Feb; 15(1):34-43. PubMed ID: 1349507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia and anticholinergic drugs.
    Gardos G; Cole JO
    Am J Psychiatry; 1983 Feb; 140(2):200-2. PubMed ID: 6129809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
    Mukherjee S; Rosen AM; Cardenas C; Varia V; Olarte S
    Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
    Grohmann R; Schmidt LG; Antretter K; Rüther E
    Internist (Berl); 1990 Jul; 31(7):468-74. PubMed ID: 1975570
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute and chronic toxicity of psychotropic drugs].
    Bickel MH
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):106-9. PubMed ID: 2431462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New findings on tardive dyskinesia in a community sample.
    O'Hara P; Brugha TS; Lesage A; Wing J
    Psychol Med; 1993 May; 23(2):453-65. PubMed ID: 8101384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia in the aged. Duration of treatment relationships.
    Toenniessen LM; Casey DE; McFarland BH
    Arch Gen Psychiatry; 1985 Mar; 42(3):278-84. PubMed ID: 2858189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent tardive dyskinesia: demographic and pharmacological risk factors.
    Muscettola G; Pampallona S; Barbato G; Casiello M; Bollini P
    Acta Psychiatr Scand; 1993 Jan; 87(1):29-36. PubMed ID: 8093821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.
    Kane JM; Smith JM
    Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profiles of tardive dyskinesia.
    Itil TM; Reisberg B; Huque M; Mehta D
    Compr Psychiatry; 1981; 22(3):282-90. PubMed ID: 6113097
    [No Abstract]   [Full Text] [Related]  

  • 19. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and intellectual disability: an examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use.
    Fodstad JC; Bamburg JW; Matson JL; Mahan S; Hess JA; Neal D; Holloway J
    Res Dev Disabil; 2010; 31(3):750-9. PubMed ID: 20207106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.